Rights and permissions
About this article
Cite this article
Amifostine worth extra cost in treating solid tumours. Pharmacoecon. Outcomes News 306, 6 (2001). https://doi.org/10.1007/BF03269262
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269262